The present invention provides methods of treating an eye disorder (i.e.,
glaucoma, macular degeneration, diabetic retinopathy, macular edema,
ocular rosacea, amblyopia, cataracts, dry eye, iritis, retinitis
pigmentosa, uveitis etc.) by administering a creatine compound to a
subject.